|
|
|
Abeta peptide and Alzheimer's disease : celebrating a
century of research
Edited by Colin J. Barrow and David H. Small
London : Springer, c2007
ISBN: 1852339616
|
If you are:
- a member of the Monash community; and
- have published, or are about to publish a book.
Let us know about it by
emailing:
authors@monash.edu.au
|
|
Book description
Abeta peptide and Alzheimer's disease : celebrating a century
of research summarizes current knowledge of beta-amyloid peptide (AB)
and its role as the major culprit in Alzheimer's Disease (AD), shown by
recent advances in genetics and brain biochemistry.
Written by leaders in the industrial and academic world specialising in this
rapidly moving area, the book covers fundamental biochemical studies on the
AB peptide, the genetic impact on AB expression and processing, and various
AD therapeutic strategies that target AB. Although specifically
focusing on AB and AD, there is also some discussion about the similarities
and differences of this peptide and AD with other amyloidogenic diseases,
such as prion, Parkinson's, and Huntington's disease.
This book will primarily be of interest to Ad researchers and clinicians but
also to researchers of other amyloid diseases.
About the author
Colin J. Barrow is the Vice President of Research and Development at Ocean Nutrition Canada in Dartmouth, Canada.
Dr David Small is a Senior Research Fellow in the Department
of Biochemistry and Molecular Biology, Faculty of Medicine, Nursing and
Health Sciences at Monash University, Melbourne, Australia.
Ask a question Phone +61 3 9905 5054 or use our enquiry services ask.monash for Monash students and staff | ask.monash for visitors, or online chat.
Your opinion Feedback form for Monash staff and students | Feedback form for visitors
|
